{"database": "lobbying", "table": "lobbying_activities", "rows": [[3231639, "85bfcb82-4e0d-4ef9-adee-3a5e07a0674d", "Q3", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2024, "third_quarter", "DEF", "Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-10-01T11:36:08-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3231639"], "units": {}, "query_ms": 14.021348091773689, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}